glp-1 receptor agonists list Overview of Available in the United States for GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Rev Diabet Stud
Endocrinol Metab (Seoul) 2023;38:2533
Retatrutide is the first medication in this class that hits 3 different biological targets
By 2030, it is expected that this number could grow to more than 1 billion people, with over 120 million of those in the U.S
Many GLP-1 pens can be kept at room temperature for a set number of days
Our physicians conduct thorough assessments before recommending any specific GLP-1 protocol, ensuring a personalised, precision medicine approach
